loading

Finanzdaten der BlossomHill Therapeutics, Inc. Common Stock-Aktie (BLSM)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2026-06-30
Periodenlänge 3 Monate
Operating Expenses
Operating Income/Loss
Net Income/Loss
Basic Average Shares
Diluted Average Shares
Basic Earnings Per Share
Diluted Earnings Per Share
$7.50
price up icon 1.35%
$10.27
price up icon 0.39%
$5.74
price up icon 5.03%
$18.93
price up icon 5.17%
$10.91
price up icon 6.03%
WVE WVE
$3.19
price up icon 3.24%
Kapitalisierung:     |  Volumen (24h):